<!DOCTYPE html>
<html lang="ja">
<head>
  <meta charset="utf-8">
  <title>REO MARUYAMA LABORATORY</title>

  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha384-MCw98/SFnGE8fJT3GXwEOngsV7Zt27NXFoaoApmYm81iuXoPkFOJwJ8ERdknLPMO" crossorigin="anonymous">
  <link href="https://use.fontawesome.com/releases/v5.6.1/css/all.css" rel="stylesheet">
  <link rel="stylesheet" href="footer.css">
</head>

<body>
  <!-- NAVIGATION BAR-->
  <nav class="navbar navbar-expand-lg navbar-light bg-white">
    <!-- toggle -->
    <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navsup" aria-controls="navsup" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>
    <!-- navbar menu -->
    <div class="collapse navbar-collapse" id="navsup">
        <a class="navbar-brand" href="#">REO MARUYAMA LAB – JFCR</a>
        <ul class="navbar-nav mr-auto">
        <li class="nav-item">
          <a class="nav-link" href="index.html">TOP</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="team.html">TEAM</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="works.html">WORKS</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="publications.html">PUBLICATIONS</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="contact.html">CONTACT</a>
        </li>
		<li class="nav-item">
          <a class="nav-link" href="recruitment.html">JOIN US!</a>
        </li>
      </ul>
    </div>
    </nav>
  <!-- NAVIGATION BAR END-->

<!-- PUBLICATION -->
<section id="PUBLICATIONS" class="bg-white">
  <div class="container" style="padding:10px;">
<p style="text-align: left">
			<br><br>
			<h3>2021</h3>
					<p>Minegishi R, Gotoh O, Tanaka N, <u>Maruyama R</u>, Chang JT, Mori S. A method of sample-wise region-set enrichment analysis for DNA methylomics. <strong><i>Epigenomics.</i></strong> 2021 Online ahead of print.<br> <p style="color:darkorange">遺伝子セットではなく領域セットの特徴を抽出するためのアルゴリズムです。各種エピゲノム解析が行われるようになり、ゲノム調節領域(cis-regulatory element)にアノテーションを付与する作業は、今後ますます重要になると思われます。CPMセンター森先生との共同研究です。</p></p>
			<p>Niinuma T, Kitajima H, Yamamoto E, <u>Maruyama R</u>, Aoki H, Harada T, Ishiguro K, Sudo G, Toyota M, Yoshido A, Kai M, Nakase H, Sugai T, Suzuki H. An Integrated Epigenome and Transcriptome Analysis to Clarify the Effect of Epigenetic Inhibitors on GIST. <strong><i>Anticancer Res.</i></strong> 2021;41:2817-2828</p>					
			<p>Horii R, Nitta H, Nojima M, <u>Maruyama R</u>, Ueno T, Ito Y, Ohno S, Banks B, Kanda H, Akiyama F. Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer. <strong><i>Virchows Arch.</i></strong> online ahead of print<br> <p style="color:darkorange">in-situで増幅と蛋白発現を同時に可視化できるGPA法という手法を用いて、乳がん組織におけるHER2増幅＋発現の腫瘍内不均一性と臨床情報との関連を解析した貴重な研究です。HER2増幅と蛋白発現に乖離の認められる症例もあり、大変興味深いです。腫瘍内不均一性（intra-tumor heterogeneity）を理解することの重要性を示唆しています。埼玉県立がんセンター（前がん研有明病院病理部）堀井先生らとの共同研究です。</p></p>
			<p>Ishiguro K, Kitajima H, Niinuma T, <u>Maruyama R</u>, Nishiyama N, Sudo G, Toyota M, Yamamoto E, Kai M, Nakase H, Suzuki H. Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. <strong><i>Cell Death Discov.</i></strong> 2021;7:7.<br> <p style="color:darkorange">ヒストン修飾酵素であるEZH2とG9aを阻害剤を用いて同時に抑制することにより、多発性骨髄腫に対して抗腫瘍効果をもたらします。大変興味深いことに、これらの阻害は内在性レトロウイルス（ERV）を活性化させインターフェロンシグナルを誘導します。エピゲノム創薬の可能性を感じます。札幌医科大学分子生物学講座の鈴木先生、石黒先生らとの共同研究です。</p></p>
			<p>Seimiya T, Otsuka M, Iwata T, Tanaka E, Sekiba K, Shibata C, Moriyama M, Nakagawa R, <u>Maruyama R</u>, Koike K. Aberrant expression of a novel circular RNA in pancreatic cancer. <strong><i>J Human Genet.</i></strong> 2021;66:181-191.</p>				
			<h3>2020</h3>
			<p>Ochi M, Otsuka M, <u>Maruyama R</u>, Koike K. HBx increases EGFR expression by inhibiting miR129–5p function. <strong><i>Biochem Biophys Res Commun.</i></strong> 2020;529:198-203.</p>
			<p>Nozawa RS, Yamamoto T, Takahashi M, Tachiwana H, <u>Maruyama R</u>, Hirota T, Saitoh N. Nuclear Microenvironment in Cancer: Control Through Liquid-Liquid Phase Separation. <strong><i>Cancer Sci.</i></strong> 2020; 111:3155-3163</p>
			<p>Yorozu A, Yamamoto E, Niinuma T,Tsuyada A, <u>Maruyama R</u>, Kitajima H, Numata Y,Kai M, Sudo G, Kubo T, Nishidate T, Okita K, Takemasa I, Nakase H, Sugai T, Takano K, Suzuki H. Upregulation of AEBP1 in endothelial cells promotes tumor angiogenesis in colorectal cancer. <strong><i>Cancer Sci.</i></strong> 2020;111:1631-1644.</p>
			<p>Fujita R, Yamamoto T, Arimura Y, Fujiwara S, Tachiwana H, Ichikawa Y, Sakata Y, <u>Yang L</u>, <u>Maruyama R</u>, Hamada M, Nakao M, Saitoh N, Kurumizaka H. Nucleosome destabilization by nuclear non-coding RNAs. <strong><i>Commun Biol.</i></strong> 2020; 3:60.</p>
			<h3>2019</h3>
			<p>Ohka F, Shinjo K, Deguchi S, Matsui Y, Okuno Y, Katsushima K, Suzuki M, Kato A, Ogiso N, Yamamichi A, Aoki K, Suzuki H, Sato S, Rayan NA, Prabhakar S, Göke J, Shimamura T, <u>Maruyama R</u>, Takahashi S, Suzumura A, Kimura H, Wakabayashi T, Zong H, Natsume A, Kondo Y. Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-wild-type Diffuse Astrocytic Gliomas. <strong><i>Cancer Res.</i></strong> 2019; 79:4814-4827.</p>
				<p>Niinuma T, Kitajima H, Kai M, Yamamoto E, Yorozu A, Ishiguro K, Sasaki H, Sudo G, Toyota M, Hatahira T, <u>Maruyama R</u>, Tokino T, Nakase H, Sugai T, Suzuki H. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells. <strong><i>Clin Epigenetics.</i></strong> 2019;11:70.</p>
			<h3>2018</h3>
			<p>Johmura Y, Maeda I, Suzuki N, Wu W, Goda A, Morita M, Yamaguchi K, Yamamoto M, Nagasawa S, Kojima Y, Tsugawa K, Inoue N, Miyoshi Y, Osako T, Akiyama F, <u>Maruyama R</u>, Inoue J, Furukawa Y, Ohta T, Nakanishi M. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. <strong><i>J Clin Invest.</i></strong> 2018;128:5603-5619.</p>
			<p>Wu W, Rokutanda N, Takeuchi J, Lai Y, <u>Maruyama R</u>, Togashi Y, Nishikawa H, Arai N, Miyoshi Y, Suzuki N, Saeki Y, Tanaka K, Ohta T. HERC2 promotes BLM and WRN to suppress G-quadruplex DNA. <strong><i>Cancer Res.</i></strong> 2018;78:6371-6385.</p>
			<p>Ishiguro K, Kitajima H, Niinuma T, Ishida T, <u>Maruyama R</u>, Ikeda H, Hayashi T, Sasaki H, Wakasugi H, Nishiyama K, Shindo T, Yamamoto E, Kai M, Sasaki Y, Tokino T, Nakase H, Suzuki H. DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling. <strong><i>Haematologica.</i></strong> 2018;191262.</p>
			<p>Nishiyama K, <u>Maruyama R</u>, Niinuma T, Kai M, Kitajima H, Toyota M, Hatanaka Y, Igarashi T, Kobayashi JI, Ogi K, Dehari H, Miyazaki A, Yorozu A, Yamamoto E, Idogawa M, Sasaki Y, Sugai T, Tokino T, Hiratsuka H, Suzuki H. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1. <strong><i>Cell Death Dis.</i></strong> 2018;9:826.</p>
			<p>Shindo T, Niinuma T, Nishiyama N, Shinkai N, Kitajima H, Kai M, <u>Maruyama R</u>, Tokino T, Masumori N, Suzuki H. Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer. <strong><i>Oncotarget.</i></strong> 2018;9:24457-24469.</p>
			  <p>Shindo T, Shimizu T, Nojima M, Niinuma T, <u>Maruyama R</u>, Kitajima H, Kai M, Itoh N, Suzuki H, Masumori N. Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study. <strong><i>Urology.</i></strong> 2018;113:71-78.</p>
			 
			  <p> </p>			  
              <p> </p>
			  <strong>
					<a href="https://researchmap.jp/reo/"> (その他丸山発表論文等詳細. researchmapへのリンク)</p></a></strong>
</p>
    </div>
</section>


<!-- PUBLICATION END -->

<!-- FOOTER -->
<footer class="footer">
   <div class="container-fluid">
     <p class="text-white mt-2">Copyright © 2020 Japanese Foundation For Cancer Research. All Rights Reserved.</p>
   </div>
</footer>

<!-- jQuery, Popper.js, bootstrap.min.js -->
  <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.3/umd/popper.min.js" integrity="sha384-ZMP7rVo3mIykV+2+9J3UJ46jBk0WLaUAdn689aCwoqbBJiSnjAK/l8WvCWPIPm49" crossorigin="anonymous"></script>
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
</body>
</html>
